POSTER: MPN-524 Reductions in Indolent Systemic Mastocytosis Biomarker Burden With Avapritinib in the Registrational, Double-Blind, Placebo-Controlled PIONEER Trial

Clinical Lymphoma, Myeloma & Leukemia(2023)

Cited 0|Views14
No score
Key words
avapritinib,double-blind,placebo-controlled
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined